Chemoinformaics analysis of  Dihydrobrassicasterol
| Molecular Weight | 400.691 | nRot | 5 |
| Heavy Atom Molecular Weight | 352.307 | nRig | 20 |
| Exact Molecular Weight | 400.371 | nRing | 4 |
| Solubility: LogS | -7.006 | nHRing | 0 |
| Solubility: LogP | 7.308 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 77 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 29 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 48 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 28 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 79.5681 |
| nHD | 1 | BPOL | 48.1539 |
| QED | 0.47 |
| Synth | 4.35 |
| Natural Product Likeliness | 2.676 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.377 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -4.74 |
| MDCK | 0.00000891 |
| BBB | 0.854 |
| PPB | 0.986758 |
| VDSS | 1.842 |
| FU | 0.0178981 |
| CYP1A2-inh | 0.055 |
| CYP1A2-sub | 0.523 |
| CYP2c19-inh | 0.071 |
| CYP2c19-sub | 0.957 |
| CYP2c9-inh | 0.093 |
| CYP2c9-sub | 0.216 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.445 |
| CYP3a4-inh | 0.181 |
| CYP3a4-sub | 0.769 |
| CL | 17.948 |
| T12 | 0.015 |
| hERG | 0.04 |
| Ames | 0.032 |
| ROA | 0.023 |
| SkinSen | 0.176 |
| Carcinogencity | 0.067 |
| EI | 0.01 |
| Respiratory | 0.502 |
| NR-Aromatase | 0.012 |
| Antiviral | No |
| Prediction | 0.695432 |